Cases started on MDR-TB treatment in Libya

Libya: Cases started on MDR-TB treatment was 13 in 2023. ◆ Volatile

Latest (2023)
13
Change on year
down 27.8%
World rank
113th
of 193 countries
All-time high
18
in 2022
All-time low
0
in 2014
Years of data
10
2009–2023

Cases started on MDR-TB treatment in Libya, 2009–2023

051015202009201620232009: 32011: 22014: 02015: 02018: 02019: 32020: 152021: 72022: 182023: 13

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for cases started on mdr-tb treatment in Libya is 13, measured in 2023.

Compared with earlier readings it is down 27.8% on the previous year.

Over the whole period, cases started on mdr-tb treatment in Libya peaked at 18 in 2022 and was at its lowest, 0, in 2014.

Libya ranks 113th of 193 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Averages by decade

DecadeAverage LowestHighest Years
2000s 3 3 3 1
2010s 1 0 3 5
2020s 13.25 7 18 4

Countries ranked near Libya

  1. 110 Norway 15 compare
  2. 110 Honduras 15 compare
  3. 112 Czechia 14 compare
  4. 113 Estonia 13 compare
  5. 113 Netherlands 13 compare
  6. 116 Switzerland 12 compare
  7. 116 Tunisia 12 compare
  8. 116 Eritrea 12 compare

See the full ranking of 205 places →

More health data for Libya

All data for Libya →

Frequently asked questions

What is cases started on mdr-tb treatment in Libya?
Cases started on mdr-tb treatment in Libya was 13 in 2023, according to World Health Organization, Global Health Observatory.
What is the highest cases started on mdr-tb treatment recorded in Libya?
The highest recorded value was 18 in 2022.
What is the lowest cases started on mdr-tb treatment recorded in Libya?
The lowest recorded value was 0 in 2014.
How does Libya rank for cases started on mdr-tb treatment?
Libya ranks 113th out of 193 countries with data for 2023.
Where does this Libya data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

About this data

Indicator
Cases started on MDR-TB treatment
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,209 data points, 2005–2024
Last refreshed